Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial
Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a small platform or display update without changing the underlying study details.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.5.2 updates the site from v3.5.0 in the footer. This appears to be a minor maintenance update with no change to study content or functionality.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedUpdated the disease terminology from 'Mucopolysaccharidosis type 4A' to 'Mucopolysaccharidosis, MPS-IV-A' across the study page.SummaryDifference0.1%

- Check48 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0. - No visible changes to study content or layout.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding notice and Revision: v3.4.1 text; these are administrative changes that do not affect the study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.